Medicines Co. (MDCO) Reports Q2 EPS of $2.51

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. CRWD
4. VRTX
5. ON
6. CHKP
7. HNGE
8. INSP
9. RXRX
10. MTCH

Go back to Medicines Co. (MDCO) Reports Q2 EPS of $2.51

The Medicines Company Reports Second-Quarter 2016 Business and Financial Results

July 27, 2016 7:01 AM EDT

Advanced potential blockbuster R&D programs

Completed divestiture of non-core cardiovascular assets

Refinanced substantial portion of near-term debt obligations

Transactions significantly strengthen balance sheet and provide valuable strategic and operational flexibility

PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ: MDCO) today announced its business and financial results for the second quarter ended June 30, 2016.

During the second quarter of 2016, the Company delivered strong execution against its strategic objectives by driving further advancement of its four potential blockbuster development... More